Annual report [Section 13 and 15(d), not S-K Item 405]

Note 16 - Income Taxes - Deferred Tax Assets and Liabilities (Details)

v3.26.1
Note 16 - Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Non-capital losses carried forward $ 40,316 $ 32,240  
Research and development expenditures 817 817  
Patents and other 460 400  
Share-based compensation 419 284  
Share issue costs 379 275  
Accruals 92 256  
Property and equipment (71) (89)  
Total deferred tax asset, net 42,412 34,183  
Valuation allowance (42,412) (34,183) $ (28,039)
Net deferred tax asset $ 0 $ 0